Abstract
Nowadays, chemoprevention by administering natural supplements is considered an attractive strategy to reverse, suppress, or prevent the evolution of premalignant oral lesions. In particular, Barbaloin exhibits anti-proliferative, anti-inflammatory, and anti-cancer properties, and it results useful in multi-therapy with classic chemotherapeutics. Therefore, in this work, mucoadhesive buccal films, as locoregional drug delivery system able to provide a targeted and efficient therapeutic delivery of Barbaloin, are proposed. Thus, Aloin extract-loaded Eudragit® RL100 or Eudragit® RS100-based buccal films were designed in order to obtain an easily self-administrable formulation capable of promoting Barbaloin penetration into buccal mucosa and assuring high patient compliance. Large amounts of extract (44%) were loaded into the polymer matrix and six formulations were prepared varying polymers and plasticizers ratios. For all formulations, physical form (thermogravimetric analysis-differential scanning calorimetry, TGA-DSC), swelling degree, mucoadhesiveness, drug release, and ability to promote drug penetration in mucosa have been investigated. After a sequential selection process, Eudragit RS 100-based film, with low PVP and high plasticizers amounts, emerged as the most promising. It results appropriately flexible, uniform in terms of weight, thickness and drug content, as well as characterized by suitable surface pH, good mucoadhesiveness, and low swelling degree. It displays a Higuchian drug release behavior up to 89% of Barbaloin released, thus demonstrating that diffusion through the matrix is the main release mechanism. Remarkable penetration enhancer properties of film were demonstrated by evidence of Barbaloin accumulation into buccal mucosa up to 10-fold higher than those obtained following administration of Aloin solution.
Similar content being viewed by others
References
Nguyen S, Hiorth M. Advanced drug delivery systems for local treatment of the oral cavity. Ther Deliv. 2015;6(5):595–608.
Sankar V, Hearnden V, Hull K, Juras DV, Greenberg M, Kerr A et al. Local drug delivery for oral mucosal diseases: challenges and opportunities. Oral Dis. 17(s1):73–84.
van der Waal I. Potentially malignant disorders of the oral and oropharyngeal mucosa; terminology, classification and present concepts of management. Oral Oncol. 2009;45(4–5):317–23.
Johnson JJ, Miller DL, Jiang R, Liu Y, Shi Z, Tarwater L et al.. Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB activation suppresses inflammation-associated tumor suppressor MicroRNAs in oral squamous cell carcinoma. J Biol Chem. 2016;291(13):6936–45.
Goodson ML, Sloan P, Robinson CM, Cocks K, Thomson PJ. Oral precursor lesions and malignant transformation—who, where, what, and when? Br J Oral Maxillofac Surg. 2015;53(9):831–5.
Coppen C, de Wilde PCM, Pop LA, van den Hoogen FJA, Merkx MAW. Treatment results of patients with a squamous cell carcinoma of the buccal mucosa. Oral Oncol. 2006;42(8):795–9.
Mallery S, Desai K-G, Holpuch A, Schwendeman S. Optimizing therapeutic efficacy of chemopreventive agents: a critical review of delivery strategies in oral cancer chemoprevention clinical trials. J Carcinog. 2011;10(1):23.
Fotedar V, Fotedar S, Seam RK, Gupta MK. Oral cancer and chemoprevention. Int J Pharm Sci Inv. 2013;2(2):16–20.
Ramshankar V, Krishnamurthy A. Chemoprevention of oral cancer: green tea experience. J Nat Sci Biol Med. 2014;5(1):3–7.
Adeeb S, Fazli W, Sup LY. Curcumin in cancer chemoprevention: molecular targets, pharmacokinetics, bioavailability, and clinical trials. Arch Pharm (Weinheim). 343(9):489–99.
Harlev E, Nevo E, Lansky EP, Ofir R, Bishayee A. Anticancer potential of aloes: antioxidant, antiproliferative, and immunostimulatory attributes. Planta Med. 2012;78(9):843–52.
Choi S, Chung M-H. A review on the relationship between aloe vera components and their biologic effects. Semin Integr Med. 2003;1(1):53–62.
Zhong J, Huang Y, Ding W, Wu X, Wan J, Luo H. Chemical constituents of Aloe barbadensis Miller and their inhibitory effects on phosphodiesterase-4D. Fitoterapia. 2013;91:159–65.
Esmat AY, Said MM, Khalil SA. Aloin: a natural antitumor anthraquinone glycoside with iron chelating and non-atherogenic activities. Pharm Biol. 2015;53(1):138–46.
Liu FW, Liu FC, Wang YR, Tsai HI, Yu HP. Aloin protects skin fibroblasts from heat stress-induced oxidative stress damage by regulating the oxidative defense system. PLoS One. 2015;10(12):1–14.
Niciforovic A, Adzic M, Zaric BRM. Adjuvant antiproliferative and cytotoxic effect of aloin in irradiated HeLaS3 cells. Russ J Phys Chem. 2007;9(81):1463–6.
Park MY, Kwon HJ, Sung MK. Dietary aloin, aloesin, or aloe-gel exerts anti-inflammatory activity in a rat colitis model. Life Sci. 2011;88(11–12):486–92.
Lucini L, Pellizzoni M, Pellegrino R, Pietro MG, Colla G. Phytochemical constituents and in vitro radical scavenging activity of different Aloe species. Food Chem. 2015;170:501–7.
Kumar S, Matharasi DP, Gopi S, Sivakumar SNS. Synthesis of cytotoxic and antioxidant Schiff’s base analogs of aloin. J Asian Nat Prod Res. 2010;5(12):360–70.
Tabolacci C, Rossi S, Lentini A, Provenzano B, Turcano L, Facchiano F et al. Aloin enhances cisplatin antineoplastic activity in B16-F10 melanoma cells by transglutaminase-induced differentiation. Amino Acids. 2013;44(1):293–300.
Hamiza OO, Rehman MUKR. Chemopreventive effects of aloin against 1,2-dimethylhydrazine-induced preneoplastic lesions in the colon of Wistar rats. Hum Exp Toxicol. 2014;33:148–63.
Salamat-Miller N, Chittchang M, Johnston T. The use of mucoadhesive polymers in buccal drug delivery. Adv Drug Deliv Rev. 2005;57(11):1666–91.
Dixit RP, Puthli SP. Oral strip technology: overview and future potential. J Control Release. 2009;139(2):94–107.
Gal JY, Fovet Y, Adib-Yadzi M. About a synthetic saliva for in vitro studies. Talanta. 2001;53(6):1103–15.
Scaturro AL, De Caro V, Campisi G, Giannola LI. Potential transbuccal delivery of l-DOPA methylester prodrug: stability in the environment of the oral cavity and ability to cross the mucosal tissue. Drug Deliv. 2016;23(7):2355–62.
Mahesh A, Shastri N, Sadanandam M. Development of taste masked fast disintegrating films of levocetirizine dihydrochloride for oral use. Curr Drug Deliv. 2010;7(1):21–7.
Irfan M, Rabel S, Bukhtar Q, Qadir MI, Jabeen F, Khan A. Orally disintegrating films: a modern expansion in drug delivery system. Saudi Pharm J. 2016;24(5):537–46.
Senthilkumar K, Vijaya C. Formulation development of mouth dissolving film of Etoricoxib for pain management. Adv Pharm. 2015;2015:1–11.
Kassem MA, Elmeshad AN, Fares AR. Enhanced bioavailability of buspirone hydrochloride via cup and core buccal tablets: formulation and in vitro/in vivo evaluation. Int J Pharm. 2014;463(1):68–80.
Semalty M, Semalty A, Kumar G. Formulation and characterization of mucoadhesive buccal films of glipizide. Indian J Pharm Sci. 2008;70(1):43–8.
Giannola LI, De Caro V, Giandalia G, Siragusa MG, D’Angelo M, Lo Muzio L et al. Transbuccal tablets of carbamazepine: formulation, release and absorption pattern. Int J Immunopathol Pharmacol. 2005;18(3 Suppl):21–31.
Siepmann J, Siepmann F. Mathematical modeling of drug delivery. Int J Pharm. 2008;364(2):328–43.
Frenning G. Modelling drug release from inert matrix systems: from moving-boundary to continuous-field descriptions. Int J Pharm. 2011;418(1):88–99.
Siepmann J, Peppas NA. Higuchi equation: derivation, applications, use and misuse. Int J Pharm. 2011;418(1):6–12.
De Caro V, Giandalia G, Siragusa MG, Sutera FM, Giannola LI. New prospective in treatment of Parkinson’s disease: studies on permeation of ropinirole through buccal mucosa. Int J Pharm. 2012.
Dash S, Murthy PN, Nath L, Chowdhury P. Kinetic modeling on drug release from controlled drug delivery systems. Acta Pol Pharm. 2010;67(3):217–23.
Sudhakar Y, Kuotsu K, Bandyopadhyay AK. Buccal bioadhesive drug delivery—a promising option for orally less efficient drugs. J Control Release. 2006;114(1):15–40.
Mura P, Cirri M, Mennini N, Casella G, Maestrelli F. Polymeric mucoadhesive tablets for topical or systemic buccal delivery of clonazepam: effect of cyclodextrin complexation. Carbohydr Polym. 2016;152:755–63.
Joshi M. Role of Eudragit in targeted drug delivery. Int J Curr Pharm Res. 2013;5(2):58–62.
Bravo-Osuna I, Vauthier C, Farabollini A, Palmieri GF, Ponchel G. Mucoadhesion mechanism of chitosan and thiolated chitosan-poly(isobutyl cyanoacrylate) core-shell nanoparticles. Biomaterials. 2007;28(13):2233–43.
Sfondrini MF, Fraticelli D, Barbati M, Scribante A, Gandini P. Effects of a new pharmaceutical preparation on the soft tissues healing after apthous lesions in pediatric patients. Dent Cadmos. 2012;80(6):334–9.
Mennella JA, Beauchamp GK. Optimizing oral medications for children. Clin Ther. 2008;30(11):2120–32.
Hutteau F, Mathlouthi M, Portmann MO, Kilcast D. Physicochemical and psychophysical characteristics of binary mixtures of bulk and intense sweeteners. Food Chem. 1998;63(1):9–16.
De Caro V, Giandalia G, Siragusa MG, Giannola LI. Buccal delivery of Methimazole as an alternative means for improvement of drug bioavailability: permeation studies and matrix system design. Curr Pharm Des. 2012;18(34):5405–10.
Sarı A, Biçer A, Karaipekli A. Synthesis, characterization, thermal properties of a series of stearic acid esters as novel solid–liquid phase change materials. Mater Lett. 2009;63(13):1213–6.
Sax G, Winter G. Mechanistic studies on the release of lysozyme from twin-screw extruded lipid implants. J Control Release. 2012;163(2):187–94.
Nair AB, Kumria R, Harsha S, Attimarad M, Al-Dhubiab BE, Alhaider IA. In vitro techniques to evaluate buccal films. J Control Release. 2013;166(1):10–21.
Andrews GP, Laverty TP, Jones DS. Mucoadhesive polymeric platforms for controlled drug delivery. Eur J Pharm Biopharm. 2009;71(3):505–18.
De Caro V, Ajovalasit A, Sutera FM, Murgia D, Sabatino MA, Dispenza C. Development and characterization of an amorphous solid dispersion of furosemide in the form of a sublingual bioadhesive film to enhance bioavailability. Pharmaceutics. 2017;9(3).
Pan Q, Pan H, Lou H, Xu Y, Tian L. Inhibition of the angiogenesis and growth of Aloin in human colorectal cancer in vitro and in vivo. Cancer Cell Int. 2013;13:69.
Acknowledgments
Authors are thankful to Dr. Francesco Carfì Pavia and ATeN Center of Palermo for technical support for DSC analyses.
Funding
Associazione Italiana per la Ricerca sul Cancro (Italian Association for Cancer Research) MFAG 2017 Id.19982.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Di Prima, G., Conigliaro, A. & De Caro, V. Mucoadhesive Polymeric Films to Enhance Barbaloin Penetration Into Buccal Mucosa: a Novel Approach to Chemoprevention. AAPS PharmSciTech 20, 18 (2019). https://doi.org/10.1208/s12249-018-1202-1
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-018-1202-1